Physician profile
Julia Johnson
NPI 1144847336
$1,231.63
in general payments reported to CMS, 2019-2025
15 companies · $255 in 2025
The $255 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $282 · 2023: $646 · 2024: $48.76 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $859 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $859.17 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $343.66 | 2022-2023 | Sotyktu |
| Optinose US, INC. | $213.16 | 2024-2025 | |
| Leo Pharma INC. | $122.95 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.55 | 2023 | Spevigo |
| Janssen Biotech, INC. | $95.40 | 2023 | Tremfya, Simponi, Simponi Aria |
| Regeneron Healthcare Solutions, INC. | $48.59 | 2023 | Dupixent |
| Glaxosmithkline, LLC. | $46.85 | 2024-2025 | Nucala |
| Pfizer INC. | $46.26 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $44.44 | 2023 | |
| Amgen INC. | $34.33 | 2023 | Otezla |
| Genzyme Corporation | $27.48 | 2025 | |
| Ucb, INC. | $25.71 | 2023 | Cimzia |
| Sun Pharmaceutical Industries INC. | $24.16 | 2023 | Blu-U |
| Incyte Corporation | $20.00 | 2022 | |
| Paratek Pharmaceuticals, INC. | $16.09 | 2025 | Xhance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.